Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 121

1.

The effect of dietary fucoidan on growth, immune functions, blood characteristics and oxidative stress resistance of juvenile red sea bream, Pagrus major.

Sony NM, Ishikawa M, Hossain MS, Koshio S, Yokoyama S.

Fish Physiol Biochem. 2018 Oct 5. doi: 10.1007/s10695-018-0575-0. [Epub ahead of print]

PMID:
30291545
2.

Endo-fucoidan hydrolases from glycoside hydrolase family 107 (GH107) display structural and mechanistic similarities to α-L-fucosidases from GH29.

Vickers C, Liu F, Abe K, Salama-Alber O, Jenkins ML, Springate CM, Burke JE, Withers SG, Boraston AB.

J Biol Chem. 2018 Oct 3. pii: jbc.RA118.005134. doi: 10.1074/jbc.RA118.005134. [Epub ahead of print]

3.

Immune Activation of RAW264.7 Macrophages by Low Molecular Weight Fucoidan Extracted from New Zealand Undaria pinnatifida.

Bi D, Yu B, Han Q, Lu J, White WL, Lai Q, Cai N, Luo W, Gu L, Li S, Xu H, Hu Z, Nie S, Xu X.

J Agric Food Chem. 2018 Oct 8. doi: 10.1021/acs.jafc.8b03698. [Epub ahead of print]

PMID:
30257559
4.

Improved chemotherapy against breast cancer through immunotherapeutic activity of fucoidan decorated electrostatically assembled nanoparticles bearing doxorubicin.

Pawar VK, Singh Y, Sharma K, Shrivastav A, Sharma A, Singh A, Meher JG, Singh P, Raval K, Kumar A, Bora HK, Datta D, Lal J, Chourasia MK.

Int J Biol Macromol. 2018 Sep 13. pii: S0141-8130(18)31817-8. doi: 10.1016/j.ijbiomac.2018.09.059. [Epub ahead of print]

PMID:
30219515
5.

Combination of fucoidan-based magnetic nanoparticles and immunomodulators enhances tumour-localized immunotherapy.

Chiang CS, Lin YJ, Lee R, Lai YH, Cheng HW, Hsieh CH, Shyu WC, Chen SY.

Nat Nanotechnol. 2018 Aug;13(8):746-754. doi: 10.1038/s41565-018-0146-7. Epub 2018 May 14.

PMID:
29760523
6.
7.

Structural characterization of a polysaccharide from Sargassum henslowianum, and its immunomodulatory effect on gastric cancer rat.

Han M, Sun P, Li Y, Wu G, Nie J.

Int J Biol Macromol. 2018 Mar;108:1120-1127. doi: 10.1016/j.ijbiomac.2017.12.109. Epub 2017 Dec 21.

PMID:
29274428
8.

Macrophage scavenger receptor 1 contributes to pathogenesis of fulminant hepatitis via neutrophil-mediated complement activation.

Tang Y, Li H, Li J, Liu Y, Li Y, Zhou J, Zhou J, Lu X, Zhao W, Hou J, Wang XY, Chen Z, Zuo D.

J Hepatol. 2017 Nov 14. pii: S0168-8278(17)32433-9. doi: 10.1016/j.jhep.2017.11.010. [Epub ahead of print]

PMID:
29154963
9.

Preclinical Evaluation of Safety of Fucoidan Extracts From Undaria pinnatifida and Fucus vesiculosus for Use in Cancer Treatment.

Mathew L, Burney M, Gaikwad A, Nyshadham P, Nugent EK, Gonzalez A, Smith JA.

Integr Cancer Ther. 2017 Dec;16(4):572-584. doi: 10.1177/1534735416680744. Epub 2016 Dec 21.

10.

Fucoidans Stimulate Immune Reaction and Suppress Cancer Growth.

Vetvicka V, Vetvickova J.

Anticancer Res. 2017 Nov;37(11):6041-6046.

PMID:
29061783
11.

The Protective and Immunomodulatory Effects of Fucoidan Against 7,12-Dimethyl benz[a]anthracene-Induced Experimental Mammary Carcinogenesis Through the PD1/PDL1 Signaling Pathway in Rats.

Xue M, Liang H, Tang Q, Xue C, He X, Zhang L, Zhang Z, Liang Z, Bian K, Zhang L, Li Z.

Nutr Cancer. 2017 Nov-Dec;69(8):1234-1244. doi: 10.1080/01635581.2017.1362446. Epub 2017 Oct 18.

PMID:
29043842
12.

Fabrication and Cytotoxicity of Fucoidan-Cisplatin Nanoparticles for Macrophage and Tumor Cells.

Hwang PA, Lin XZ, Kuo KL, Hsu FY.

Materials (Basel). 2017 Mar 14;10(3). pii: E291. doi: 10.3390/ma10030291.

13.

Low molecular weight fucoidan and its fractions inhibit renal epithelial mesenchymal transition induced by TGF-β1 or FGF-2.

Li X, Li X, Zhang Q, Zhao T.

Int J Biol Macromol. 2017 Dec;105(Pt 2):1482-1490. doi: 10.1016/j.ijbiomac.2017.06.058. Epub 2017 Jun 13.

PMID:
28627391
14.

Fucoidan modulates cytokine production and migration of THP‑1‑derived macrophages via colony‑stimulating factor‑1.

Li P, Wang H, Shao Q, Kong B, Qu X.

Mol Med Rep. 2017 Apr;15(4):2325-2332. doi: 10.3892/mmr.2017.6228. Epub 2017 Feb 22.

PMID:
28259971
15.

[Morphofunctional changes of dendritic cells induced by sulfated polysaccharides of brown algae].

Makarenkova ID, Akhmatova NK, Ermakova SP, Besednova NN.

Biomed Khim. 2017 Jan;63(1):39-46. doi: 10.18097/PBMC2017630139. Russian.

PMID:
28251950
16.

Seaweed extracts and galacto-oligosaccharides improve intestinal health in pigs following Salmonella Typhimurium challenge.

Bouwhuis MA, McDonnell MJ, Sweeney T, Mukhopadhya A, O'Shea CJ, O'Doherty JV.

Animal. 2017 Sep;11(9):1488-1496. doi: 10.1017/S1751731117000118. Epub 2017 Feb 13.

PMID:
28190419
17.

Fucoidan reduced the invasion of oral squamous cell carcinoma cells and modified their effects to macrophages.

Lin J, Wang K, Wang H, Shao Q, Luan Y, Xu Y, Song X, Tan W, Liu S, Wei F, Qu X.

Med Oncol. 2017 Jan;34(1):9. doi: 10.1007/s12032-016-0858-1. Epub 2016 Dec 21.

PMID:
28004293
18.

The scavenger receptor repertoire in six cnidarian species and its putative role in cnidarian-dinoflagellate symbiosis.

Neubauer EF, Poole AZ, Weis VM, Davy SK.

PeerJ. 2016 Nov 15;4:e2692. eCollection 2016. Erratum in: PeerJ. 2017 Jun 6;4:.

19.

White shrimp Litopenaeus vannamei that have received fucoidan exhibit a defense against Vibrio alginolyticus and WSSV despite their recovery of immune parameters to background levels.

Chen YY, Kitikiew S, Yeh ST, Chen JC.

Fish Shellfish Immunol. 2016 Dec;59:414-426. doi: 10.1016/j.fsi.2016.10.050. Epub 2016 Nov 2.

PMID:
27815206
20.

Fucoidan inhibits CCL22 production through NF-κB pathway in M2 macrophages: a potential therapeutic strategy for cancer.

Sun J, Sun J, Song B, Zhang L, Shao Q, Liu Y, Yuan D, Zhang Y, Qu X.

Sci Rep. 2016 Oct 24;6:35855. doi: 10.1038/srep35855.

Supplemental Content

Loading ...
Support Center